His lab is focusing on refining the alanine-scanning assay to a few key residues that will properly distinguish among fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological diagnosis, And perhaps for blood screening of tauopathies.Immerse by yourself in TAU’s Daring and emotional